Trendlines Group's ElastiMed Expands Medical Wearables to US Market; Shares Drop 2%

MT Newswires
05/19

The Trendlines (SGX:42T) signed a strategic distribution agreement with a US-based medical technology company, according to a Monday filing with the Singapore Exchange.

Shares of the company were down nearly 2% in Tuesday trading.

Under the agreement, the company's brand, ElastiMed will gain access to the US market for its MyoSleeve wearable compression device.

MyoSleeve's technology aims at the treatment of venous and lymphatic conditions.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10